FDA-PDS Symposium III: Intermediate Endpoints in Immuno-Oncology
Keynote
The Role of Data Sharing in Fulfilling FDA’s Vision of an Evidence Generation System
Robert M. Califf, MD, Commissioner, FDA
Main sessions
Project Data Sphere Initiative Update: Outcomes Since Symposium II
- Dean Bottino, PhD, Millennium Pharmaceuticals
- Antonio Fojo, MD, PhD, Columbia University
- Martin Murphy, DMedSc, PhD, FASCO, Project Data Sphere
- Mace Rothenberg, MD, Pfizer Oncology
- Oliver Sartor, MD, Tulane Cancer Center
Information Exchange and Data Transformation (INFORMED) Initiative Update
- Sean Khozin, MD, MPH, FDA
- Adrian Myers, FDA
- Anand Shah, MD, FDA
- Vahan Simonyan, PhD, FDA
Research on Intermediate Endpoints in Immuno-Oncology
- Jeff Allen, PhD, Friends of Cancer Research
- Gideon Blumenthal, MD, FDA
- Ellen Sigal, PhD, FDA
- Rajeshwari Sridhara, PhD, FDA
Attendees
AbbVie
Alliance for Clinical Trials
Alliance for Clinical Trials in Oncology
AstraZeneca
Breast Oncology Center | Dana-Farber Cancer Institute
Carmine Research
C-Change
Center for Biomedical Informatics & Information Technology, NCI
Columbia University Medical Center
ECOG-ACRIN
EMD Serono
Flatiron Health
Focused Ultrasound Foundation
Friends of Cancer Research
Hogan Lovells
James J. Peters VA Hospital Cancer Center
Johns Hopkins University
Merck and Co., Inc.
Memorial Sloan Kettering Cancer Center
National Cancer Institute, NIH
NeoImmuneTech, Inc.
Novartis
Pfizer, Inc.
RA Capital Management
SAS
Takeda Oncology
Tulane University
U.S. Department of Health and Human Services